Serratus Anterior Plane Block Versus Paravertebral Block for Postmastectomy Analgesia (SAM)
Breast Cancer, Acute Pain
About this trial
This is an interventional treatment trial for Breast Cancer focused on measuring serratus, paravertebral, breast, cancer, axilla
Eligibility Criteria
Inclusion Criteria:
- unilateral mastectomy with or without axillary lymph node dissection.
- American Society of Anesthesia (ASA) I&II
Exclusion Criteria:
- morbid obesity (body mass index > 40 kg/m2);
- renal insufficiency (creatinine > 1.5 mg/dL),
- current chronic analgesic therapy (daily use > 4 weeks),
- a history of opioid dependence, pregnancy,
- inability to communicate with the investigators or hospital staff,
- American Society of Anesthesia (ASA) III-IV
Sites / Locations
- National Cancer Institute
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Serratus anterior muscle plane block
Paravertebral block
Serratus anterior muscle plane block with general anesthesia MARCAINE® 0.25%w/v solution for injection. DIPRIVAN® (propofol), 2 to 2.5 mg/kg NIMBEX® (cisatracurium besylate) Injection, 0.15-0.2 mg\Kg Fentanyl, 1-2 mic\Kg Paracetamol, 1000 mg\6 hours Fam® (Ketorolac), 30 mg
Paravertebral block with general anesthesia. MARCAINE® 0.25%w/v solution for injection. DIPRIVAN® (propofol), 2 to 2.5 mg/kg NIMBEX® (cisatracurium besylate) Injection, 0.15-0.2 mg\Kg Fentanyl, 1-2 mic\Kg Paracetamol, 1000 mg\6 hours Fam® (Ketorolac), 30 mg